Barely Significant
← all excerpts

Chemoprevention in Skin Cancer: What Advice?

Cancers (Basel) · 2026 · PMC12896719 · PMID 41681908

1
hedged sentence
closest p
boldest claim

The sentences

found that the COX-2 inhibitor celecoxib decreased the development of new BCCs in patients with PTCH1 +/− basal cell nevus syndrome, but it did not reach statistical significance [ 44 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.